Crypto - DOGE Square Wave Ponzi Cycle
Updated
Idea for Dogecoin:
- Testing Function Square Wave indicator Trial #2.
- Wyckoff Distribution mapped.
- Expected to capitulate near target date to target level:
GLHF,
DPT
Disclaimer:
We absolutely do not provide financial advice in any shape or form. We do not recommend investing based on our opinions and strongly cautions that securities trading and investment involves high risk and that you can lose a lot of money. Loss of principal is possible. We do not recommend risking money you cannot afford to lose. We do not guarantee future performance nor accuracy in historical analyses. We are not registered investment advisors. Our ideas, opinions and statements are not a substitute for professional investment advice. We provide ideas containing impersonal market observations and our opinions. Our speculations may be used in preparation to form your own ideas.
- Testing Function Square Wave indicator Trial #2.
- Wyckoff Distribution mapped.
- Expected to capitulate near target date to target level:
GLHF,
DPT
Disclaimer:
We absolutely do not provide financial advice in any shape or form. We do not recommend investing based on our opinions and strongly cautions that securities trading and investment involves high risk and that you can lose a lot of money. Loss of principal is possible. We do not recommend risking money you cannot afford to lose. We do not guarantee future performance nor accuracy in historical analyses. We are not registered investment advisors. Our ideas, opinions and statements are not a substitute for professional investment advice. We provide ideas containing impersonal market observations and our opinions. Our speculations may be used in preparation to form your own ideas.
Trade active
Goldman Sachs MD quits prestigious position after making a "fortune" on DOGE. The Ponzi is over.Wolong v2
Trade active
Trial Success - drop forecasted on daily candle, price likely to reach level in continued downtrend.
Related publications
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.